NCT06263660

Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression

Exploratory Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Effect of a Keto-Like Supplement in Depressed Patients on Functional Brain Responses to Positive and Negative Stimuli
Laureate Institute for Brain Research, Inc.·Phase 2·ClinicalTrials.gov·dietary supplementRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Depression
Drug/Device/Intervention
Keto-like supplement
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Laureate Institute for Brain Research, Inc.
Location
Tulsa, United States of America
Timeline & enrollment
Phase
Phase 2
Start date
Jan 09, 2024
End date
Jan 01, 2026
Enrollment
75 participants
Primary outcome

BOLD response during Monetary Incentive Delay Task

Summary

This study aims to determine whether a keto-like supplement relative to placebo results in
 functional brain changes during fMRI tasks evaluating positive and negative valence in
 individuals with moderate to severe depression. In this double-blind randomized
 placebo-controlled trial, 75 individuals with a Patient Health Questionnaire (PHQ-9) scale
 score ≥ 10 (MDD) will be enrolled to participate in an 8-week treatment study to obtain 60
 completers. Participants will be randomized with a 1-1 ratio to receive the keto-like
 supplement (n= 30 completers) or placebo (n=30 completers) taken orally three times per day
 for 8 weeks. Participants will undergo a 10.5-hour screening/baseline evaluation visit split
 over 2 days at week 0 including questionnaires, neuroimaging before and after supplement or
 placebo administration and blood draws, office visits at week 2 (1.5 hours), week 4 (3
 hours), week 6 (0.5 hours), week 8 (6 hours), a follow-up visit at week 10 (1.5 hours) and
 two phone calls between visits (weeks 1 and 3) during which a brief clinical assessment will
 be obtained (10 minutes each). The total time involved in the study is approximately 23.5
 hours.

ICD-10 classifications
Depressive episodeOther depressive episodesRecurrent depressive disorderRecurrent depressive disorder, unspecifiedPost-schizophrenic depression
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06263660
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06263660 through Pure Global AI's free database. This Phase 2 trial is sponsored by Laureate Institute for Brain Research, Inc. and is currently Recruiting. The study focuses on Depression. Target enrollment is 75 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.